{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "PAR", "shortName": "IPSEN", "longName": "Ipsen S.A.", "messageBoardId": "finmb_135238", "exchangeTimezoneName": "Europe/Paris", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "fr_market", "esgPopulated": false, "regularMarketChangePercent": 0.53523505, "regularMarketPrice": 112.7, "marketState": "POSTPOST", "fiftyTwoWeekHighChangePercent": -0.0114035355, "fiftyTwoWeekLow": 80.0, "fiftyTwoWeekHigh": 114.0, "earningsTimestamp": 1690455540, "earningsTimestampStart": 1690455540, "earningsTimestampEnd": 1690455540, "trailingAnnualDividendRate": 1.204, "trailingPE": 15.696379, "trailingAnnualDividendYield": 0.010740411, "epsTrailingTwelveMonths": 7.18, "epsForward": 8.82, "epsCurrentYear": 8.38, "priceEpsCurrentYear": 13.448687, "sharesOutstanding": 82029400, "bookValue": 40.384, "fiftyDayAverage": 106.952, "fiftyDayAverageChange": 5.7479935, "fiftyDayAverageChangePercent": 0.05374367, "twoHundredDayAverage": 102.4865, "twoHundredDayAverageChange": 10.213493, "twoHundredDayAverageChangePercent": 0.09965696, "marketCap": 9244712960, "forwardPE": 12.777778, "priceToBook": 2.7907093, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "2.6 - Hold", "tradeable": false, "cryptoTradeable": false, "priceHint": 2, "regularMarketChange": 0.5999985, "regularMarketTime": 1683905708, "regularMarketDayHigh": 113.6, "regularMarketDayRange": "112.4 - 113.6", "regularMarketDayLow": 112.4, "regularMarketVolume": 45676, "regularMarketPreviousClose": 112.1, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "Paris", "financialCurrency": "EUR", "regularMarketOpen": 112.9, "averageDailyVolume3Month": 68832, "averageDailyVolume10Day": 63666, "fiftyTwoWeekLowChange": 32.699997, "fiftyTwoWeekLowChangePercent": 0.40874997, "fiftyTwoWeekRange": "80.0 - 114.0", "fiftyTwoWeekHighChange": -1.300003, "firstTradeDateMilliseconds": 1133942400000, "symbol": "IPN.PA"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "65, quai Georges Gorse", "city": "Boulogne-Billancourt", "zip": "92100", "country": "France", "phone": "33 1 58 33 50 00", "fax": "33 1 58 33 50 01", "website": "https://www.ipsen.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, and rare diseases. It offers Somatuline for neuroendocrine tumors and acromegaly; Dysport for motor muscular disorders and medical aesthetics; Decapeptyl for the treatment of advanced metastatic prostate cancer; Cabometyx for renal cell and second-line hepatocellular carcinoma; Onivyde for second-line metastatic pancreatic cancer; and Tazverik to treat third-line follicular lymphoma. The company also provides NutropinAq for growth failure in children due to growth hormone (GH) deficiency, turner syndrome or chronic renal insufficiency, and GH deficiency in adults; and Increlex for growth failure in children and adolescents. In addition, it offers Xermelo for the treatment of carcinoid syndrome; and Cometriq to treat medullary thyroid cancer. Ipsen S.A. has agreements with Debiopharm; Exelixis; Galderma; Blueprint Medicines; TerSera Therapeutics; Rhythm Pharmaceuticals; Teijin; Schwabe; BAKX Therapeutics Inc.; and Exicure. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France.", "fullTimeEmployees": 5072, "companyOfficers": [{"maxAge": 1, "name": "Mr. David  Loew", "age": 55, "title": "MD, CEO & Director", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": {"raw": 2222000, "fmt": "2.22M", "longFmt": "2,222,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Aymeric  Le Chatelier", "age": 53, "title": "Exec. VP & Group CFO", "yearBorn": 1969, "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Aidan  Murphy Ph.D.", "age": 56, "title": "Exec. VP of Technical Operations", "yearBorn": 1966, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Craig  Marks", "title": "Vice-Pres of Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Francois  Garnier", "age": 60, "title": "Exec. VP of Legal Affairs, Gen. Counsel & Chief Bus. Ethics Officer", "yearBorn": 1962, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Gwenan  White", "title": "Exec. VP of Communications & Public Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Regis  Mulot", "age": 56, "title": "Exec. VP & Chief HR Officer", "yearBorn": 1966, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Dominique  Bery", "age": 51, "title": "Head of Nordics & Baltics", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Yan  Moore M.D.", "age": 55, "title": "Sr. VP & Head of Oncology Therapeutic Area", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Alexander  McEwan", "title": "Vice-Pres & Head of Radiopharmaceuticals", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 7, "overallRisk": 9, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}